JP2016530890A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016530890A5 JP2016530890A5 JP2016542356A JP2016542356A JP2016530890A5 JP 2016530890 A5 JP2016530890 A5 JP 2016530890A5 JP 2016542356 A JP2016542356 A JP 2016542356A JP 2016542356 A JP2016542356 A JP 2016542356A JP 2016530890 A5 JP2016530890 A5 JP 2016530890A5
- Authority
- JP
- Japan
- Prior art keywords
- medium
- producing
- cells
- kit
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1358909A FR3010720B1 (fr) | 2013-09-16 | 2013-09-16 | Procede de production de virus enveloppes |
| FR1358909 | 2013-09-16 | ||
| PCT/FR2014/052279 WO2015036713A1 (fr) | 2013-09-16 | 2014-09-12 | Procede de production de virus enveloppes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016530890A JP2016530890A (ja) | 2016-10-06 |
| JP2016530890A5 true JP2016530890A5 (enExample) | 2017-10-19 |
| JP6629210B2 JP6629210B2 (ja) | 2020-01-15 |
Family
ID=50424334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016542356A Ceased JP6629210B2 (ja) | 2013-09-16 | 2014-09-12 | エンベロープウイルスの産生方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10125352B2 (enExample) |
| EP (1) | EP3047025B1 (enExample) |
| JP (1) | JP6629210B2 (enExample) |
| CN (1) | CN105722984B (enExample) |
| CA (1) | CA2923554C (enExample) |
| DK (1) | DK3047025T3 (enExample) |
| ES (1) | ES2732154T3 (enExample) |
| FR (1) | FR3010720B1 (enExample) |
| RU (1) | RU2016114541A (enExample) |
| SG (1) | SG11201602017YA (enExample) |
| WO (1) | WO2015036713A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3014901B1 (fr) | 2013-12-17 | 2017-06-09 | Genethon | Procede de purification de virus ou vecteurs viraux enveloppes |
| RU2761555C2 (ru) | 2015-10-22 | 2021-12-09 | Джуно Терапьютикс Гмбх | Способы, наборы, средства и устройства для трансдукции |
| KR20220047635A (ko) | 2019-08-23 | 2022-04-18 | 론자 워커스빌 아이엔씨. | 렌티바이러스 벡터의 생산을 위한 방법 및 작제물 |
| US12365873B2 (en) | 2021-01-28 | 2025-07-22 | Allogene Therapeutics, Inc. | Methods for transducing immune cells |
| WO2023114949A1 (en) * | 2021-12-16 | 2023-06-22 | Sana Biotechnology, Inc. | Methods and systems of particle production |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005304866B2 (en) | 2004-11-05 | 2010-04-01 | Wellstat Biologics Corporation | Stable and filterable enveloped virus formulations |
| PL2007883T3 (pl) | 2006-04-20 | 2012-07-31 | Wyeth Llc | Sposób oczyszczania do izolacji oczyszczonego wirusa pęcherzykowatego zapalenia jamy ustnej z hodowli komórkowej |
| WO2009153563A1 (en) | 2008-06-18 | 2009-12-23 | Oxford Biomedica (Uk) Limited | Virus purification |
| US10596264B2 (en) * | 2011-06-30 | 2020-03-24 | Genethon | Peptides with viral infection enhancing properties and their use |
| WO2013076309A1 (en) | 2011-11-24 | 2013-05-30 | Genethon | Scalable lentiviral vector production system compatible with industrial pharmaceutical applications |
| FR3014901B1 (fr) | 2013-12-17 | 2017-06-09 | Genethon | Procede de purification de virus ou vecteurs viraux enveloppes |
-
2013
- 2013-09-16 FR FR1358909A patent/FR3010720B1/fr not_active Expired - Fee Related
-
2014
- 2014-09-12 EP EP14796166.8A patent/EP3047025B1/fr not_active Revoked
- 2014-09-12 US US15/022,049 patent/US10125352B2/en not_active Expired - Fee Related
- 2014-09-12 SG SG11201602017YA patent/SG11201602017YA/en unknown
- 2014-09-12 RU RU2016114541A patent/RU2016114541A/ru not_active Application Discontinuation
- 2014-09-12 CN CN201480050980.4A patent/CN105722984B/zh not_active Expired - Fee Related
- 2014-09-12 WO PCT/FR2014/052279 patent/WO2015036713A1/fr not_active Ceased
- 2014-09-12 CA CA2923554A patent/CA2923554C/fr not_active Expired - Fee Related
- 2014-09-12 JP JP2016542356A patent/JP6629210B2/ja not_active Ceased
- 2014-09-12 ES ES14796166T patent/ES2732154T3/es active Active
- 2014-09-12 DK DK14796166.8T patent/DK3047025T3/da active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Munis | Gene therapy applications of non-human lentiviral vectors | |
| Bobadilla et al. | Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein | |
| Tomás et al. | LentiPro26: novel stable cell lines for constitutive lentiviral vector production | |
| Benskey et al. | Lentivirus production and purification | |
| Mock et al. | Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases | |
| Gao et al. | The influenza A virus PB2, PA, NP, and M segments play a pivotal role during genome packaging | |
| JP7105875B2 (ja) | レトロウイルスベクター | |
| JP2018534937A5 (enExample) | ||
| JP2016028035A5 (enExample) | ||
| Kim et al. | Stability of retroviral vectors against ultracentrifugation is determined by the viral internal core and envelope proteins used for pseudotyping | |
| JP2018516557A (ja) | レンチウイルスベクターのバイオ生産法 | |
| Sinn et al. | Lentiviral vectors pseudotyped with filoviral glycoproteins | |
| Hermann et al. | Mutations in gp120 contribute to the resistance of human immunodeficiency virus type 1 to membrane-anchored C-peptide maC46 | |
| King et al. | Technical considerations for the generation of novel pseudotyped viruses | |
| JP2024028802A (ja) | レンチウイルスパッケージングシステム、それにより製造されたレンチウイルス、及び、該レンチウイルスで形質導入された細胞、並びに、それを使用して宿主細胞のレンチウイルスの収率を向上させる方法 | |
| JP6629210B2 (ja) | エンベロープウイルスの産生方法 | |
| JP2014530000A5 (enExample) | ||
| JPWO2020059848A1 (ja) | レンチウイルスベクター産生の増強方法 | |
| Mautino et al. | Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element | |
| CN104262477A (zh) | 一种禽CCCH型锌指蛋白chZAP及其应用 | |
| Miskin et al. | A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectors | |
| D’Costa et al. | Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation | |
| Schüle et al. | Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj | |
| Kuroda et al. | A polymorphism of the TIM-1 IgV domain: implications for the susceptibility to filovirus infection | |
| CN105274089B (zh) | 一种表达绿色荧光囊膜融合蛋白的rev病毒传染性克隆的构建方法 |